WebExtended-Infusion Cefepime (Maxipime®) Protocol . Related Documents: Patient Care Manual Guide: Medication Administration IV Infusion Guidelines . I. PURPOSE . Dose optimization is an essential component for clinical success in the treatment of serious infections as well as preventing the emergence of resistance. WebMAXIPIME and other antibacterial drugs, MAXIPIME should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION . MAXIPIME (cefepime hydrochloride, USP) is a semi-synthetic, broad spectrum, cephalosporin antibiotic for parenteral administration. The chemical name is 1-[[(6R,7R)
Reference ID: 4092515 - Food and Drug Administration
Web8 mrt. 2024 · Maxipime 2gm Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoid prolonged use of Maxipime 2gm Injection, since it may have possible effects such as rash and diarrhea. Driving CONSULT YOUR DOCTOR Webما هي استخدامات ماكسيبيم؟. يستخدم في علاج: - عدوى المسالك البولية المعقدة و البسيطة، مثل التهاب الكلوة و الحويضة. - قلة العدلات الحمّوي (كعلاج وحيد أو مع علاجات أخرى) - الالتهابات الجلدية - ذات ... philip swerts
Side Effects of Maxipime (Cefepime Hydrochloride for Injection ... - RxList
Web1 feb. 2024 · US Brand Name Maxipime Descriptions Cefepime injection is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections. Web18 mei 2024 · There are four main nursing implications: those related to medications, treatments, procedures, and patient education. Medication-Related: nursing implications … WebInfants 2 months and older, Children, and Adolescents. 50 mg/kg/dose IV every 8 hours (Max: 2 g/dose) for 7 days or until resolution of neutropenia. For patients … philip swern